Concepedia

Lorenza Borin

LB

19

Publications

1.4K

Citations

17

H-Index

1990

Active since

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Azienda Ospedaliera San Gerardo

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

University of Milan

Lorenza Borin is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, hematology, and oncology.

Top concepts

Publications per year

1990–2023

19

Publications

19

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock et al. · New England Journal of Medicine · 2020 · 403 citations · Full text

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer et al. · Journal of Clinical Oncology · 2021 · 212 citations · Full text

Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes

Maria Teresa Voso, Valeria Santini, Carlo Finelli et al. · Clinical Cancer Research · 2009 · 101 citations · Full text

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elisabetta Sauta, Marie Robin, Matteo Bersanelli et al. · Journal of Clinical Oncology · 2023 · 98 citations · Full text

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Andrew H. Wei, Hartmut Döhner, Christopher Pocock et al. · Blood · 2019 · 97 citations

Rows per page

1–5 of 19